Huw Morris is Professor of Neurology and Neurogenetics, at UCL Queen Square Institute of Neurology, and Honorary Consultant Neurologist at the Royal Free Hospital and the National Hospital, Queen Square, London. His clinical and research training took place at the National Hospita Queen Squarel, the Mayo Clinic and the Western Pacific island of Guam. He began research in PSP and related disorders as a PSP Association and MRC Clinical Research Fellow in 1997. His main interests are Neurogenetics, Movement Disorders and Dementia. He leads a UK-wide research network in PSP, Corticobasal syndrome and MSA (PROSPECT and EXPRESS) and a UK-wide research project in genetic Parkinson’s (Parkinson’s Families Project). He leads the cohort group of the Global Parkinson’s Genetics Program (gp2.org). He also studies genetic determinants of progression and variation in Parkinsonian disorders using clinical and brain bank analysis to help to define new treatments.
Cure Rare Disease, a non-profit organization (Tax ID number 82-2473513), is qualified as a tax-exempt organization under section 501(c)(3) of the IRS and has been designated as a “public charity” under section 170.
© CURE RARE DISEASE. ALL RIGHTS RESERVED.
.png)
© CURE RARE DISEASE.ALL RIGHTS RESERVED.
